FIELD: producing drugs. SUBSTANCE: method involves applying adriablastine on ferromagnetic. The process is carried out in aqueous solution, freshly prepared magnetite (Fe3O4) or carbonile ion being preliminary activated in 0.05 M normal solution of mineral acid is used as mentioned above ferromagnetic. Thus prepared magnetosensitive suspension of therapeutic agent contains, mass % : ferromagnetic 9.8-65.1, adriablastine 0.28-2.33, water to 100. Adriablastine content in desired drug is up to 86.7 mg/g, dispersity of magnetic carrier is 0.02-0.50 μm. EFFECT: improves efficiency of the method. 1 tbl
Authors
Dates
1994-08-30—Published
1991-07-08—Filed